Shibata, Stephen I <br/><br/>
Phase I trial of GTI-2040, oxaliplatin, and capecitabine in the treatment of advanced metastatic solid tumors: a California Cancer Consortium Study.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  Nov 2009 
 - 1149-55 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1432-0843 
<br/><br/><label>Standard No.: </label>10.1007/s00280-009-0977-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--administration & dosage<br/>Capecitabine<br/>Deoxycytidine--administration & dosage<br/>Drug Therapy, Combination<br/>Female<br/>Fluorouracil--administration & dosage<br/>Gene Expression--drug effects<br/>Humans<br/>Leukocytes, Mononuclear--drug effects<br/>Male<br/>Maximum Tolerated Dose<br/>Middle Aged<br/>Neoplasm Metastasis--drug therapy<br/>Neoplasms--drug therapy<br/>Oligodeoxyribonucleotides--administration & dosage<br/>Organoplatinum Compounds--administration & dosage<br/>Oxaliplatin<br/>Ribonucleoside Diphosphate Reductase--antagonists & inhibitors<br/>Treatment Outcome<br/>Tumor Suppressor Proteins--genetics